THE EFFECTS OF UMESPIRONE AS A POTENTIAL ANXIOLYTIC AND ANTIPSYCHOTIC AGENT

被引:17
作者
BARNES, NM [1 ]
COSTALL, B [1 ]
DOMENEY, AM [1 ]
GERRARD, PA [1 ]
KELLY, ME [1 ]
KRAHLING, H [1 ]
NAYLOR, RJ [1 ]
TOMKINS, DM [1 ]
WILLIAMS, TJ [1 ]
机构
[1] KALI CHEM AG,DIV PHARMACEUT,W-3000 HANNOVER,GERMANY
关键词
UMESPIRONE; ANXIOLYTIC; ANTIPSYCHOTIC;
D O I
10.1016/0091-3057(91)90326-W
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Umespirone was compared to buspirone, diazepam and clozapine as a potential anxiolytic and antipsychotic agent. In the mouse black and white test box, umespirone was considerably more potent than diazepam or buspirone to reduce aversive responding, tolerance to its effects was not observed and sedation was absent, a chronic treatment and withdrawal was not associated with an anxiogenic profile, and umespirone prevented the behavioural consequences of withdrawal from diazepam. Umespirone also had an anxiolytic profile of action in the tests of rat social interaction and in the marmoset exposed to a human threat. Both umespirone and clozapine reduced the hyperactivity induced by the infusion of dopamine into the nucleus accumbens of rat. In radioligand binding assays umespirone demonstrated nanomolar affinity for the alpha-1-adrenoceptor and the 5-HT1A and dopamine D2 receptors. It is concluded that umespirone may present as a novel psychotropic agent with anxiolytic and antipsychotic potential.
引用
收藏
页码:89 / 96
页数:8
相关论文
共 41 条
[1]  
ANDRADE R, 1987, N-S ARCH PHARMACOL, V336, P5
[2]   WITHDRAWAL SYNDROME FOLLOWING SUBCHRONIC TREATMENT WITH ANXIOLYTIC AGENTS [J].
BARRY, JM ;
COSTALL, B ;
KELLY, ME ;
NAYLOR, RJ .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1987, 27 (02) :239-245
[3]   BIOCHEMICAL AND MOLECULAR MECHANISMS OF ACTION OF NEUROLEPTICS, ALTERNATIVES TO THE CLASSICAL DOPAMINE HYPOTHESIS - MINUTES OF THE DISCUSSION GROUP [J].
BISCHOFF, S ;
BURKI, HR ;
EMRICH, HM ;
JAECKEL, J ;
KORNHUBER, J ;
RUHLAND, M ;
SCHMID, WJ ;
WOGGON, B .
PHARMACOPSYCHIATRY, 1986, 19 (04) :140-144
[4]  
BOCKAERT J, 1987, N-S ARCH PHARMACOL, V335, P588
[5]  
BURKI HR, 1975, PHARMAKOPSYCH NEURO, V8, P115
[6]   ANIMAL-MODELS OF ANXIETY - THE EFFECT OF COMPOUNDS THAT MODIFY 5-HT NEUROTRANSMISSION [J].
CHOPIN, P ;
BRILEY, M .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1987, 8 (10) :383-388
[7]   LONG-TERM CONSEQUENCES OF ANTAGONISM BY NEUROLEPTICS OF BEHAVIORAL EVENTS OCCURRING DURING MESOLIMBIC DOPAMINE INFUSION [J].
COSTALL, B ;
DOMENEY, AM ;
NAYLOR, RJ .
NEUROPHARMACOLOGY, 1984, 23 (03) :287-294
[8]   EFFECTS OF THE 5-HT3 RECEPTOR ANTAGONIST, GR38032F, ON RAISED DOPAMINERGIC ACTIVITY IN THE MESOLIMBIC SYSTEM OF THE RAT AND MARMOSET BRAIN [J].
COSTALL, B ;
DOMENEY, AM ;
NAYLOR, RJ ;
TYERS, MB .
BRITISH JOURNAL OF PHARMACOLOGY, 1987, 92 (04) :881-894
[9]   EXPLORATION OF MICE IN A BLACK AND WHITE TEST BOX - VALIDATION AS A MODEL OF ANXIETY [J].
COSTALL, B ;
JONES, BJ ;
KELLY, ME ;
NAYLOR, RJ ;
TOMKINS, DM .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1989, 32 (03) :777-785
[10]   ACTIONS OF BUSPIRONE IN A PUTATIVE MODEL OF ANXIETY IN THE MOUSE [J].
COSTALL, B ;
KELLY, ME ;
NAYLOR, RJ ;
ONAIVI, ES .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1988, 40 (07) :494-500